HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Acid sphingomyelinase deficiency: prevalence and characterization of an intermediate phenotype of Niemann-Pick disease.

AbstractOBJECTIVE:
To document the prevalence of neurologic disease in Niemann-Pick disease (NPD) NPD-B.
STUDY DESIGN:
Sixty-four patients with NPD-B had detailed neurologic and ophthalmologic evaluations. The presence of neurologic abnormalities was compared with genotype.
RESULTS:
Nineteen of 64 patients (30%) had neurologic abnormalities, which were minor and nonprogressive in 14 (22%), and global and progressive in 5 (8%). In these five patients, the onset of neurologic difficulties occurred between 2 and 7 years of age and was associated with peripheral neuropathy, retinal abnormalities, and the Q292K mutation. No patients with at least one copy of DeltaR608 had neurologic involvement.
CONCLUSIONS:
The majority of patients with NPD-B have no neurologic abnormalities. In patients with neurologic abnormalities, the findings can be minor and static or severe and progressive. The latter phenotype follows a course distinct from that of classic NPD-A and is associated with the Q292K mutation and characteristic retinal findings. Thus, similar to other lysosomal storage disorders, there is a broad spectrum of neurologic abnormalities in acid sphingomyelinase deficiency, which makes the current classification scheme inaccurate.
AuthorsMelissa P Wasserstein, Alan Aron, Scott E Brodie, Calogera Simonaro, Robert J Desnick, Margaret M McGovern
JournalThe Journal of pediatrics (J Pediatr) Vol. 149 Issue 4 Pg. 554-9 (Oct 2006) ISSN: 0022-3476 [Print] United States
PMID17011332 (Publication Type: Case Reports, Journal Article, Research Support, N.I.H., Extramural)
Topics
  • Adolescent
  • Adult
  • Aged
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Infant
  • Male
  • Middle Aged
  • Nervous System Diseases (epidemiology, etiology, genetics)
  • Niemann-Pick Diseases (complications, genetics)
  • Phenotype
  • Prevalence

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: